Outcomes in Diabetic and Nondiabetic Patients Treated With Everolimus- or Paclitaxel-Eluting Stents: Results From the SPIRIT IV Clinical Trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System)

We compared the safety and efficacy of the XIENCE V (Abbott Vascular, Santa Clara, California) everolimus-eluting stent (EES) with the TAXUS Express (Boston Scientific, Natick, Massachusetts) paclitaxel-eluting stent (PES) among the large cohort of randomized diabetic patients enrolled in the SPIRIT...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2010-12, Vol.56 (25), p.2084-2089
Hauptverfasser:	KEREIAKES, Dean J, CUTLIP, Donald E, SIMONTON, Charles A, SUDHIR, Krishnankutty, STONE, Gregg W, APPLEGATE, Robert J, WANG, John, YAQUB, Manejeh, SOOD, Poornima, XIAOLU SU, GUOPING SU, FARHAT, Naim, RIZVI, Ali
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angioplasty, Balloon, Coronary - instrumentation Biological and medical sciences Cardiology Cardiology. Vascular system Clinical outcomes Coronary Artery Disease - complications Coronary Artery Disease - therapy Coronary heart disease Diabetes. Impaired glucose tolerance Diabetic Angiopathies - therapy Drug therapy Drug-Eluting Stents Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Everolimus Female Heart Heart attacks Humans Immunosuppressive Agents - administration & dosage Male Medical sciences Middle Aged Paclitaxel - administration & dosage Prospective Studies Sirolimus - administration & dosage Sirolimus - analogs & derivatives Stents Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!